Literature DB >> 9163595

A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome.

P Noris1, S Simsek, J Stibbe, A E von dem Borne.   

Abstract

The platelet membrane glycoprotein (GP) Ib-IX-V complex, the major von Willebrand factor receptor on platelets, is absent or dysfunctional in patients with the Bernard-Soulier syndrome (BSS). The four single subunits of the GPIb-IX-V complex (GPIb alpha, Ib beta, IX and V) are molecular products of different genes. Several point mutations and deletions affecting the GPIb alpha gene have been identified as the cause of BSS, whilst in four BSS families a GPIX gene defect has been reported. Moreover, a single case of BSS has been associated with a genetic defect of GPIb beta. We investigated the molecular basis of another case of BSS with a deficient expression of GPIX, as detected by immunofluorescence studies. After amplification of the entire GPIX coding region, nucleotide sequence analysis showed a homozygous single point mutation predicting a phenylalanine to serine substitution at position 55 of the mature GPIX within its unique leucine-rich repeat. By allele-specific oligonucleotide hybridization we confirmed the homozygosity of the patient as well as the carrier state of two out of three of his children studied. Although the parents of the patient, who were first cousins, were no longer alive and thus not available for study, we speculate that the molecular defect observed in the proband was inherited from both parents, who probably were heterozygous for this GPIX gene defect. This study confirms that BSS may be caused by many different subtle molecular defects that often prevent the assembly and expression of a functional GPIb-IX-V complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163595     DOI: 10.1046/j.1365-2141.1997.582706.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Molecular characterization of tol, a mediator of mating-type-associated vegetative incompatibility in Neurospora crassa.

Authors:  P K Shiu; N L Glass
Journal:  Genetics       Date:  1999-02       Impact factor: 4.562

3.  Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations.

Authors:  Anna Savoia; Annalisa Pastore; Daniela De Rocco; Elisa Civaschi; Mariateresa Di Stazio; Roberta Bottega; Federica Melazzini; Valeria Bozzi; Alessandro Pecci; Silvana Magrin; Carlo L Balduini; Patrizia Noris
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

4.  Novel Mutation in Bernard-Soulier Syndrome.

Authors:  Kirstin Sandrock; Ralf Knöfler; Andreas Greinacher; Birgitt Fürll; Sebastian Gerisch; Ulrich Schuler; Siegmund Gehrisch; Anja Busse; Barbara Zieger
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

5.  Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study.

Authors:  Isabel Sánchez-Guiu; Ana I Antón; José Padilla; Francisco Velasco; José F Lucia; Miguel Lozano; Ana Rosa Cid; Teresa Sevivas; María F Lopez-Fernandez; Vicente Vicente; Consuelo González-Manchón; José Rivera; María L Lozano
Journal:  Orphanet J Rare Dis       Date:  2014-12-24       Impact factor: 4.123

6.  A point mutation in Phe71Ser in glycoprotein IX as a genetic cause of Bernard-Soulier syndrome: case report.

Authors:  Imtinan K Alsahafi; Ibrahim Al-Harbi; Shahad M Aldor; Bilqis A Albarakati; Ghaida B Alahmadi
Journal:  Clin Case Rep       Date:  2018-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.